Azitra, Inc. Files 2024 Annual Report

Ticker: AZTR · Form: 10-K · Filed: Feb 24, 2025 · CIK: 1701478

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceutical

TL;DR

Azitra's 2024 10-K is out. Full year financials and biz details inside.

AI Summary

Azitra, Inc. filed its 10-K for the fiscal year ending December 31, 2024, reporting its financial condition and business operations. The company, incorporated in Delaware, is based in Branford, CT, and operates in the pharmaceutical preparations sector. Key financial details and operational highlights for 2024 are presented in this comprehensive annual report.

Why It Matters

This filing provides investors and stakeholders with a detailed overview of Azitra's financial performance and strategic direction for the past fiscal year, crucial for understanding the company's current standing and future prospects.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Azitra faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed within the 10-K.

Key Numbers

Key Players & Entities

FAQ

What is Azitra, Inc.'s primary business activity?

Azitra, Inc. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code [2834].

What is the fiscal year end for this 10-K filing?

The fiscal year end for this 10-K filing is December 31, 2024.

Where is Azitra, Inc. located?

Azitra, Inc.'s business and mailing address is 21 Business Park Drive, Suite 6, Branford, CT 06405.

When was this 10-K filed with the SEC?

This 10-K was filed with the SEC on February 24, 2025.

What is Azitra's SEC file number?

Azitra's SEC file number is 001-41705.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on February 24, 2025 regarding Azitra, Inc. (AZTR).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing